No new exclusive direct supply after 2020

The National Pharmaceutical Services Association has welcomed new CSO operational guidelines, while a tender has opened for access to the CSO funding pool The new CSO deeds prohibit new exclusive direct supply arrangements after 2020, a move which NPSA chairman Mark Hooper welcomed. He also said he was pleased to see some manufacturers already transitioning